Lilly to buy non-opioid pain biotech SiteOne for up to $1B

endpts.com/lilly-to-buy-non-opioid-pain-biotech-siteone-for-up-to-1b

John Mulcahy, SiteOne Therapeutics CEO
Lilly to buy non-opioid pain biotech SiteOne for up to $1B
Eli Lilly is deepening its presence in the non-opioid pain field by buying California biotech SiteOne Therapeutics, which is in a similar arena as the …

This story appeared on endpts.com, 2025-05-27 17:46:08.839000.
The Entire Business World on a Single Page. Free to Use →